公司概覽
業務類別 Biotechnology
業務概覽 Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.
公司地址 25 N 38th Street, 11th Floor, Philadelphia, PA, USA, 19104
電話號碼 +1 267 817-5790
傳真號碼 --
公司網頁 https://www.centurytx.com
員工數量 150
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Brent Pfeiffenberger, M.B.A.,Pharm.D. Chairman of the Board, President and Chief Executive Officer 美元 625.00K 14/08/2025
Dr. Hyam I. Levitsky,M.D. President of Research and Development -- 26/04/2024
Dr. Chad Cowan, PhD Chief Scientific Officer -- 22/04/2025
Mr. Douglas Carr Interim Principal Financial Officer -- 07/07/2025
Dr. Gregory Russotti, PhD Chief Technology and Manufacturing Officer 美元 542.50K 22/04/2025
 
董事會成員
董事會 職務 更新日期
Dr. Brent Pfeiffenberger, M.B.A.,Pharm.D. Chairman of the Board, President and Chief Executive Officer 14/08/2025
Mr. Timothy P. Walbert Independent Director 22/04/2025
Dr. Martin Patrick Murphy, PhD Independent Director 09/12/2025
Ms. Daphne E. Quimi Independent Director 22/04/2025
Dr. Han Myung Lee Independent Director 09/12/2025
Dr. Kimberly L. Blackwell, M.D. Independent Director 22/04/2025
Dr. Alessandro Riva, M.D. Independent Director 22/04/2025
 
所屬ETF (更新日期: 07/03/2026 02:08)
代號 名稱 佔比% 持有日期
AVSCAvantis US Small Cap Equity ETF0.01%28/02/2026
GUGGuggenheim Active Allocation Fund0.0001%30/11/2025
HDGProShares Hedge Replication<0.000001%30/06/2025
ITWOProShares Russell 2000 High Income ETF<0.000001%30/06/2025
IWCiShares Micro-Cap ETF<0.000001%28/02/2026
IWNiShares Russell 2000 Value ETF<0.000001%28/02/2026
IWViShares Russell 3000 ETF<0.000001%28/02/2026
MSSMMorgan Stanley Pathway Sm-Md Cp Eq ETF<0.000001%30/06/2025
RSSLGlobal X Russell 2000 ETF<0.000001%30/06/2025
SCHASchwab US Small-Cap ETF™<0.000001%23/09/2025
SMMDiShares Russell 2500 ETF<0.000001%27/02/2026
URTYProShares UltraPro Russell2000<0.000001%30/06/2025
UWMProShares Ultra Russell2000<0.000001%30/06/2025
VTWOVanguard Russell 2000 ETF<0.000001%30/06/2025
VTWVVanguard Russell 2000 Value ETF<0.000001%30/06/2025
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.